Gene Regulation, Stem Cells and Cancer
- Group page
- Research lines
- Group members
1990 PhD in Biological Sciences by the Department of Biochemistry and Molecular Biology, Autónoma University of Madrid (Spain).
1992-1996 Postdoctoral Research Associate in Joel D. Richter's laboratory. Worcester Foundation for Biomedical Research, Massachusetts (USA).
1996-2000 Postdoctoral Research Associate in Matthias W. Hentze's laboratory. European Molecular Biology Laboratory - EMBL-, (Germany).
2001 Staff Scientist at EMBL.
2002 Group Leader at the Center for Genomic Regulation - CRG- Barcelona (Spain).
CRG scientists will explore new treatments for Retinitis Pigmentosa and melanoma (25/07/2018)
La Caixa Banking Foundation announced today the 20 awarded projects in its 1st Health Research Call. The CRG will lead and host two of the twenty awarded projects out of the more than 780 projects that were submitted. CRG group leaders Maria Pia Cosma and Fátima Gebauer will receive funding to develop their projects, which will explore new treatments for retinal degeneration and melanoma metastasis and progression respectively.
Our group is interested in the regulation of mRNA translation by RNA-binding proteins (RBPs). This type of regulation is widely used in Biology to modulate processes such as metabolism, cell differentiation, embryonic patterning or synaptic transmission. We wish to understand the molecular mechanisms of translational control and the RNA networks that are established to maintain cell homeostasis. We are interested on how de-regulation of RBP function leads to disease, in particular to cancer.
Other information about the group
We acknowledge the financial contribution of the Spanish Ministry of Economy and Competitiveness, and the European Regional Development Fund (ERDF) to the development of the project “Role of RNA binding proteins in translation and tumorigenesis” (Ref. BFU2015-68741). We also acknowledge the contribution of DURSI (Ref. 2017SGR534), Marató-TV3 (Ref 201314) and La Caixa Foundation (HR17-00232).